Christine Siu

Christine Siu is a Board Member at Monte Rosa Therapeutics and has over 15 years of experience in the biotech industry. Christine has held various leadership positions at companies such as Eidos Therapeutics, The Bluefield Project to Cure Frontotemporal Dementia, and Global Blood Therapeutics, Inc. In their most recent role as Life Science Chief Business Officer Consultant at White Rose Partners Inc, they provided strategic and financial guidance to life science companies. Prior to that, they were a Venture Principal at Third Rock Ventures and Vice President at Thomas, McNerney & Partners. Christine has a deep understanding of the biotech landscape and is passionate about helping companies achieve their goals.

Christine Siu has a Master of Business Administration (MBA) from Harvard Business School and a Bachelor of Science (B.S.) with Distinction in Cellular Molecular Biology & Economics from the University of Michigan.